Cerca Insights Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
19
- Latest Deal Type
-
M&A
Cerca Insights General Information
Description
Provider of research and development services for behavioral pharmacologies. The company provides services such as phenotyping new rodent models, behavioral assay development and ageing studies.
Contact Information
Website
www.cercainsights.comCorporate Office
- Plot Number 36, Level 2, Hilir Sungai Keluang 2
- Bayan Lepas Industrial Estate, Phase IV
- Bayan Lepas, Penang 11900
- Malaysia
Corporate Office
- Plot Number 36, Level 2, Hilir Sungai Keluang 2
- Bayan Lepas Industrial Estate, Phase IV
- Bayan Lepas, Penang 11900
- Malaysia
Cerca Insights Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Jan-2014 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 29-Mar-2010 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | Completed | Generating Revenue | ||||
| 1. Grant | 01-Jan-2008 | $752K | Completed | Generating Revenue |
Cerca Insights Patents
Cerca Insights Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20070249646-A1 | Alleviating symptoms of neuropsychiatric disorders such as schizophrenia comprising administering ritalin related compounds such as 2-(4-phenylphenyl)-2-[-1,2,3,6-tetrahydropyridin-2-yl]acetate | Active | 10-Mar-2006 | ||
| US-7851487-B2 | Alleviating symptoms of neuropsychiatric disorders such as schizophrenia comprising administering ritalin related compounds such as 2-(4-phenylphenyl)-2-[-1,2,3,6-tetrahydropyridin-2-yl]acetate | Inactive | 10-Mar-2006 | ||
| JP-2009529535-A | Use of tetrahydropyridine in the treatment of central nervous system disorders | Inactive | 10-Mar-2006 | ||
| EP-1998771-A2 | Use of tetrahydropyridines in the treatment of central nervous system disorders | Active | 10-Mar-2006 | ||
| EP-1998771-A4 | Use of tetrahydropyridines in the treatment of central nervous system disorders | Active | 10-Mar-2006 | C07D211/70 |
Cerca Insights Signals
Cerca Insights Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Burrill & Co | Merchant Banking Firm | Minority | ||
| Malaysian Technology Development Corporation | Venture Capital | Minority | ||
| Spruce Capital Partners | Venture Capital | Minority | ||
| Xeraya Capital | Venture Capital | Minority |
Cerca Insights FAQs
-
When was Cerca Insights founded?
Cerca Insights was founded in 2000.
-
Where is Cerca Insights headquartered?
Cerca Insights is headquartered in Bayan Lepas, Malaysia.
-
What is the size of Cerca Insights?
Cerca Insights has 19 total employees.
-
What industry is Cerca Insights in?
Cerca Insights’s primary industry is Other Healthcare Services.
-
Is Cerca Insights a private or public company?
Cerca Insights is a Private company.
-
What is Cerca Insights’s current revenue?
The current revenue for Cerca Insights is .
-
How much funding has Cerca Insights raised over time?
Cerca Insights has raised $6.04M.
-
Who are Cerca Insights’s investors?
Burrill & Co, Malaysian Technology Development Corporation, Spruce Capital Partners, and Xeraya Capital have invested in Cerca Insights.
-
When was Cerca Insights acquired?
Cerca Insights was acquired on 01-Jan-2014.
-
Who acquired Cerca Insights?
Cerca Insights was acquired by Psychogenics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process